Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.25 is in line with its 5-year average of 4.22, near the low end of its 5-year range (1.67–15.85).
As of the fiscal period ended Tuesday, June 30, 2026. 42.33% above its 12-month average of 2.99.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.25.
CURRENT RATIO
4.25
CURRENT RATIO AVG TTM
2.99
CURRENT RATIO AVG 3Y
2.82
CURRENT RATIO AVG 5Y
4.22
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+42.33%
CURRENT VS 3Y AVG
+51.00%
CURRENT VS 5Y AVG
+0.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+13.43%
vs the sector median at left
Market Cap
$60.24M
Current Ratio
10.98
TTM Avg
17.43
3Y Avg
9.10
5Y Avg
12.08
Market Cap
$58.44M
Current Ratio
0.57
TTM Avg
2.81
3Y Avg
4.44
5Y Avg
7.47
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xilio Therapeutics, Inc. (XLO) | $59.18M | 4.25 | 2.99 | 2.82 | 4.22 |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | 1.35 | 1.97 | 5.50 | 8.52 |
| Kalaris Therapeutics Inc (KLRS)vs › | $60.24M | 10.98 | 17.43 | 9.10 | 12.08 |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | 3.15 | 4.21 | 4.67 | 4.26 |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.94M | 1.23 | 0.89 | 0.93 | 1.06 |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | 0.57 | 2.81 | 4.44 | 7.47 |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | 6.71 | 8.38 | 9.61 | 10.03 |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | 9.48 | 13.86 | 12.45 | 13.81 |
| Talphera, Inc. (TLPH)vs › | $57.61M | 4.29 | 4.53 | 3.35 | 3.13 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | 2.37 | 7.60 | 7.51 | 12.19 |
Current Ratio
4.25
Quick Ratio
4.25
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.25 |
| 2026-03-31 | 3.59 |
| 2025-12-31 | 2.58 |
| 2025-09-30 | 2.20 |
| 2025-06-30 | 2.32 |
| 2025-03-31 | 1.96 |
| 2024-12-31 | 2.21 |
| 2024-09-30 | 1.67 |
| 2024-06-30 | 2.02 |
| 2024-03-31 | 2.19 |
| 2023-12-31 | 3.02 |
| 2023-09-30 | 3.81 |
| 2023-06-30 | 4.81 |
| 2023-03-31 | 5.99 |
| 2022-12-31 | 5.89 |
| 2022-09-30 | 8.45 |
| 2022-06-30 | 9.17 |
| 2022-03-31 | 14.81 |
| 2021-12-31 | 15.85 |
| 2021-09-30 | 8.20 |
| 2021-06-30 | 5.85 |
| 2021-03-31 | 8.75 |
| 2020-12-31 | 0.93 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
